Yu F - Search Results

1

Selenium: 48-year journey of global clinical trials.

Wu Y, Pei J, Xu Y, Yu F, Xu S. Wu Y, et al. Among authors: yu f. Mol Cell Biochem. 2025 Jan 4. doi: 10.1007/s11010-024-05202-x. Online ahead of print. Mol Cell Biochem. 2025. PMID: 39755855 Review.

2

[High mobility group nucleosome binding protein 1 (HMGN1) induces activation of mouse BV2 microglia and upregulates their pro-inflammatory mediator expression by activating TLR4/MyD88/NF-κB p65/IKK-β signal pathway].

Mao Y, Yu J, Yuan J, DA J, Yu F, Zha Y. Mao Y, et al. Among authors: yu f, yu j. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Feb;40(2):135-141. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024. PMID: 38284254 Chinese.

3

HomeoboxC6 affects the apoptosis of human vascular endothelial cells and is involved in atherosclerosis.

Long X, You G, Wu Q, Zhou Y, Xiao Y, Yu F, Deng S, Mo R, Song F, Huang J, Tian M. Long X, et al. Among authors: yu f. J Cell Physiol. 2021 Mar;236(3):1913-1925. doi: 10.1002/jcp.29974. Epub 2020 Aug 1. J Cell Physiol. 2021. PMID: 32740941

4

Abnormal protein SUMOylation in liver disease: novel target for therapy.

Yang Y, Yu F. Yang Y, et al. Among authors: yu f. J Mol Med (Berl). 2024 Jun;102(6):719-731. doi: 10.1007/s00109-024-02440-w. Epub 2024 Apr 3. J Mol Med (Berl). 2024. PMID: 38565749 Review.

5

Endoplasmic reticulum stress in breast cancer: a predictive model for prognosis and therapy selection.

Yang B, Wang S, Yang Y, Li X, Yu F, Wang T. Yang B, et al. Among authors: yu f. Front Immunol. 2024 Feb 19;15:1332942. doi: 10.3389/fimmu.2024.1332942. eCollection 2024. Front Immunol. 2024. PMID: 38440732 Free PMC article.

6

PM_2.5 exposure aggravates kidney damage by facilitating the lipid metabolism disorder in diabetic mice.

Jiang Y, Peng Y, Yang X, Yu J, Yu F, Yuan J, Zha Y. Jiang Y, et al. Among authors: yu f, yu j. PeerJ. 2023 Sep 1;11:e15856. doi: 10.7717/peerj.15856. eCollection 2023. PeerJ. 2023. PMID: 37671359 Free PMC article.

7

Deciphering breast cancer prognosis: a novel machine learning-driven model for vascular mimicry signature prediction.

Li X, Li X, Yang B, Sun S, Wang S, Yu F, Wang T. Li X, et al. Among authors: yu f. Front Immunol. 2024 Aug 6;15:1414450. doi: 10.3389/fimmu.2024.1414450. eCollection 2024. Front Immunol. 2024. PMID: 39165361 Free PMC article.

8

Acteoside alleviates UUO-induced inflammation and fibrosis by regulating the HMGN1/TLR4/TREM1 signaling pathway.

Mao Y, Yu J, Da J, Yu F, Zha Y. Mao Y, et al. Among authors: yu f, yu j. PeerJ. 2023 Jan 18;11:e14765. doi: 10.7717/peerj.14765. eCollection 2023. PeerJ. 2023. PMID: 36691481 Free PMC article.

9

Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature.

Li X, Li X, Yang B, Sun S, Wang S, Yu F, Wang T. Li X, et al. Among authors: yu f. Front Immunol. 2024 May 1;15:1369289. doi: 10.3389/fimmu.2024.1369289. eCollection 2024. Front Immunol. 2024. PMID: 38756785 Free PMC article.

10

Central administration of Dapagliflozin alleviates a hypothalamic neuroinflammatory signature and changing tubular lipid metabolism in type 2 diabetic nephropathy by upregulating MCPIP1.

Da J, Xu Y, Tan Y, Zhang J, Yu J, Zhao J, Da Q, Yu F, Zha Y. Da J, et al. Among authors: yu f, yu j. Biomed Pharmacother. 2023 Dec;168:115840. doi: 10.1016/j.biopha.2023.115840. Epub 2023 Nov 6. Biomed Pharmacother. 2023. PMID: 37931516 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,131 results

Search Page

Filters